idoxuridine has been researched along with Myelodysplastic Syndromes in 4 studies
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
Excerpt | Relevance | Reference |
---|---|---|
"Sixty-eight patients with myelodysplastic syndromes (MDS) received sequential infusions of iodo- and/or bromodeoxyuridine for cell kinetic analysis." | 7.69 | Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. ( Alston, D; Alvi, S; Borok, RZ; Broady-Robinson, L; Cartlidge, J; Chopra, HK; Dar, SE; Gezer, S; Gregory, SA; Hernandez, B; Hines, C; Loew, J; Mundle, SD; Parcharidou, A; Raza, A; Rifkin, S; Robin, E; Shah, R; Shetty, VT; Showel, J; Showel, M; Span, L; Venugopal, P, 1997) |
"Sixty-eight patients with myelodysplastic syndromes (MDS) received sequential infusions of iodo- and/or bromodeoxyuridine for cell kinetic analysis." | 3.69 | Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. ( Alston, D; Alvi, S; Borok, RZ; Broady-Robinson, L; Cartlidge, J; Chopra, HK; Dar, SE; Gezer, S; Gregory, SA; Hernandez, B; Hines, C; Loew, J; Mundle, SD; Parcharidou, A; Raza, A; Rifkin, S; Robin, E; Shah, R; Shetty, VT; Showel, J; Showel, M; Span, L; Venugopal, P, 1997) |
"Examination of the proliferative characteristics of myeloblasts was undertaken in situ in bone marrow (BM) biopsies of patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following sequential infusions of iodo- (IUdR) and bromodeoxyuridine (BrdU)." | 3.68 | In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies. ( Akhtar, S; Bohkari, SA; Chughtai, S; Masterson, M; Mehdi, SA; Miller, MA; Raza, A; Sheikh, Y; Umerani, A; Yousuf, N, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mundle, S | 1 |
Iftikhar, A | 1 |
Shetty, V | 1 |
Dameron, S | 1 |
Wright-Quinones, V | 1 |
Marcus, B | 1 |
Loew, J | 2 |
Gregory, S | 1 |
Raza, A | 3 |
Alvi, S | 1 |
Broady-Robinson, L | 1 |
Showel, M | 1 |
Cartlidge, J | 1 |
Mundle, SD | 1 |
Shetty, VT | 1 |
Borok, RZ | 1 |
Dar, SE | 1 |
Chopra, HK | 1 |
Span, L | 1 |
Parcharidou, A | 1 |
Hines, C | 1 |
Gezer, S | 1 |
Venugopal, P | 1 |
Showel, J | 1 |
Alston, D | 1 |
Hernandez, B | 1 |
Rifkin, S | 1 |
Robin, E | 1 |
Shah, R | 1 |
Gregory, SA | 1 |
Yousuf, N | 1 |
Bohkari, SA | 1 |
Sheikh, Y | 1 |
Akhtar, S | 1 |
Chughtai, S | 1 |
Umerani, A | 1 |
Mehdi, SA | 1 |
Miller, MA | 1 |
Masterson, M | 1 |
Naito, K | 1 |
Yamada, K | 1 |
4 other studies available for idoxuridine and Myelodysplastic Syndromes
Article | Year |
---|---|
Novel in situ double labeling for simultaneous detection of proliferation and apoptosis.
Topics: Acute Disease; Apoptosis; Bone Marrow; Bromodeoxyuridine; Cell Division; DNA; DNA, Neoplasm; Hematop | 1994 |
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine.
Topics: Apoptosis; Bromodeoxyuridine; Cell Cycle; DNA; Humans; Idoxuridine; Myelodysplastic Syndromes | 1997 |
In situ cell cycle kinetics in bone marrow biopsies following sequential infusions of IUdR/BrdU in patients with hematopoietic malignancies.
Topics: Biopsy; Biopsy, Needle; Bone Marrow; Bromodeoxyuridine; Cell Cycle; Humans; Idoxuridine; Leukemia, M | 1992 |
[Serum deoxythymidine kinase in hematological malignancy].
Topics: Acute Disease; Adult; Chronic Disease; Humans; Idoxuridine; Leukemia; Myelodysplastic Syndromes; Thy | 1988 |